Telomir Pharmaceuticals, Inc. reports

Location
100 Se 2 Nd St, Suite 2000 #1009, Miami, FL
State of incorporation
Florida
Fiscal year end
December 31
Data updated at
9/5/2024, 01:20 AM
Form type Sec Links Description Filing date Reporting date
8-K Report | Data Sep 3, 2024 Sep 3, 2024
10-Q Report | Data Aug 13, 2024 Jun 30, 2024
8-K Report | Data Jun 24, 2024 Jun 18, 2024
10-Q Report | Data May 13, 2024 Mar 31, 2024
8-K Report | Data Apr 15, 2024 Apr 15, 2024
8-K Report | Data Apr 12, 2024 Apr 12, 2024
10-K Report | Data Mar 29, 2024 Dec 31, 2023
8-K Report | Data Feb 13, 2024 Feb 8, 2024